4GW4 image
Deposition Date 2012-08-31
Release Date 2013-04-17
Last Version Date 2024-11-20
Entry Detail
PDB ID:
4GW4
Keywords:
Title:
Crystal structure of 3BNC60 Fab with P61A mutation
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.65 Å
R-Value Free:
0.25
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:3BNC60 Fab Heavy-chain
Mutagens:P61A
Chain IDs:B (auth: H), C (auth: A)
Chain Length:229
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:3BNC60 Fab Light-chain
Chain IDs:A (auth: L), D (auth: B)
Chain Length:206
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN D ASN GLYCOSYLATION SITE
PCA B GLN PYROGLUTAMIC ACID
Ligand Molecules
Primary Citation
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization.
Cell(Cambridge,Mass.) 153 126 138 (2013)
PMID: 23540694 DOI: 10.1016/j.cell.2013.03.018

Abstact

Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs are highly somatically mutated and generated by a fraction of HIV-1-infected individuals several years after infection. Antibodies typically accumulate mutations in the complementarity determining region (CDR) loops, which usually contact the antigen. The CDR loops are scaffolded by canonical framework regions (FWRs) that are both resistant to and less tolerant of mutations. Here, we report that in contrast to most antibodies, including those with limited HIV-1 neutralizing activity, most bNAbs require somatic mutations in their FWRs. Structural and functional analyses reveal that somatic mutations in FWR residues enhance breadth and potency by providing increased flexibility and/or direct antigen contact. Thus, in bNAbs, FWRs play an essential role beyond scaffolding the CDR loops and their unusual contribution to potency and breadth should be considered in HIV-1 vaccine design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures